BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33603343)

  • 21. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
    Yao S; Ye J; Yin M; Yu R
    Cancer Lett; 2020 Jul; 483():87-97. PubMed ID: 32268165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity.
    Bian M; Wang X; Sun Y; Liu W
    Eur J Med Chem; 2020 May; 193():112234. PubMed ID: 32213395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma.
    Yin Y; Guo J; Teng F; Yu L; Jiang Y; Xie K; Jiang M; Fang J
    Drug Des Devel Ther; 2019; 13():4173-4184. PubMed ID: 31849449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calycosin induces mitochondrial-dependent apoptosis and cell cycle arrest, and inhibits cell migration through a ROS-mediated signaling pathway in HepG2 hepatocellular carcinoma cells.
    Liu Y; Piao XJ; Xu WT; Zhang Y; Zhang T; Xue H; Li YN; Zuo WB; Sun G; Fu ZR; Luo YH; Jin CH
    Toxicol In Vitro; 2021 Feb; 70():105052. PubMed ID: 33188878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma.
    Zhang Y; Zhao L; Li X; Wang Y; Yao J; Wang H; Li F; Li Z; Guo Q
    Arch Toxicol; 2014 Jan; 88(1):97-107. PubMed ID: 23835921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cordycepin Affects Multiple Apoptotic Pathways to Mediate Hepatocellular Carcinoma Cell Death.
    Zhou Y; Guo Z; Meng Q; Lu J; Wang N; Liu H; Liang Q; Quan Y; Wang D; Xie J
    Anticancer Agents Med Chem; 2017; 17(1):143-149. PubMed ID: 27225448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
    Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
    J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells.
    Yang J; Yang Y; Tian L; Sheng XF; Liu F; Cao JG
    World J Gastroenterol; 2011 Oct; 17(38):4298-307. PubMed ID: 22090786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
    Ahmed NM; Youns M; Soltan MK; Said AM
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactive components and mechanisms of poplar propolis in inhibiting proliferation of human hepatocellular carcinoma HepG2 cells.
    Liu H; Li J; Yuan W; Hao S; Wang M; Wang F; Xuan H
    Biomed Pharmacother; 2021 Dec; 144():112364. PubMed ID: 34700230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
    Gao C; Li X; Yu S; Liang L
    J BUON; 2019; 24(5):1964-1969. PubMed ID: 31786862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eucalrobusone C suppresses cell proliferation and induces ROS-dependent mitochondrial apoptosis via the p38 MAPK pathway in hepatocellular carcinoma cells.
    Jian KL; Zhang C; Shang ZC; Yang L; Kong LY
    Phytomedicine; 2017 Feb; 25():71-82. PubMed ID: 28190473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27
    Tang Y; Chen J; Li J; Zheng Y; Zhong X; Huang S; Chen B; Peng B; Zou X; Chen X
    Phytomedicine; 2021 Jun; 86():153563. PubMed ID: 33951569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK.
    Yang XH; Zheng X; Cao JG; Xiang HL; Liu F; Lv Y
    World J Gastroenterol; 2010 Jul; 16(27):3385-93. PubMed ID: 20632440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. III-10, a newly synthesized flavonoid, induces cell apoptosis with the involvement of reactive oxygen species-mitochondria pathway in human hepatocellular carcinoma cells.
    Dai Q; Yin Q; Zhao Y; Guo R; Li Z; Ma S; Lu N
    Eur J Pharmacol; 2015 Oct; 764():353-362. PubMed ID: 26164795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.